Healthcare is one of the most regulated industries in the United States, yet it is unclear how pricing mechanisms are developed within different parts of the system. This lack of access and information causes ripple effects.

All Pricing Transparency Items

The White House to Drop another Price-Related Executive Order?
Healthcare In Transition | Jul. 17, 2019 | Government Affairs, Healthcare, Healthcare costs, Healthcare reform, Payment reform, Prescription Drug Pricing, Pricing transparency

July 18, 2019 President Trump announced the administration’s intention to release an executive order based on a “favored nations” clause. This approach suggests the U.S. would pay for pharmaceuticals at

Executive Order on Healthcare Pricing Transparency
Healthcare In Transition | Jul. 17, 2019 | Association health plans, Government Affairs, Healthcare, Healthcare reform, Pricing transparency, Short term health plan

June 18, 2019 The White House recently released an executive order aimed at requiring insurers, physicians and hospitals to provide patients with more digestible information about the cost of their

Healthcare Reform: Legislation Trackers
Healthcare In Transition | Jun. 20, 2019 | ACA, Healthcare, Payment reform, Pharmacy supply chain, Prescription Drug Pricing, Pricing transparency, Single Payer, Surprise Medical Billing

June 20, 2019 Our legal team at Steptoe & Johnson tracks healthcare reform bills in the 116th Congress. These documents are updated as of June 14. Federal Healthcare Reform Tracker.

Government Affairs Roundup: The Latest on Healthcare Policy
Healthcare In Transition | May. 16, 2019 | ACA, Access to Care, Employer Sponsored Insurance, Government Affairs, Healthcare, Healthcare costs, Healthcare data, Healthcare reform, Payment reform, Prescription Drug Pricing, Pricing transparency, Single Payer, state activity, Surprise Medical Billing, Technology

Surprise Medical Billing Broad bipartisan support from the Trump administration as well as Congress has created momentum around surprise medical billing. Earlier this week, the House Energy and Commerce Committee

The Latest on Healthcare from our Government Affairs Duo
Healthcare In Transition, Video | Apr. 18, 2019 | ACA, Association health plans, Government Affairs, Healthcare, Healthcare costs, Healthcare reform, Medicare, Payment reform, Prescription Drug Pricing, Pricing transparency

April 18, 2019 Joel Wood, SVP, Government Affairs and Joel Kopperud, VP, Government Affairs, give us the lowdown on AHPs, the ACA, Medicare for All and drug pricing—and what we can

What We’re Watching on Capitol Hill
Healthcare In Transition | Mar. 21, 2019 | Access to Care, Government Affairs, Healthcare costs, Healthcare reform, Individual insurance market, Payment reform, Prescription Drug Pricing, Pricing transparency, Pricing transparency, Reinsurance, Surprise Medical Billing

March 21, 2019 Our Government Affairs team is monitoring bills and action items that would affect the insurance industry. Here’s what we’re focusing on as of late: The “Short on

What Happens When Employers Leverage Their Purchasing Power (Leader’s Edge)
Jan. 25, 2019 | Employer Sponsored Insurance, Healthcare costs, Leader’s Edge, Payment reform, Pricing transparency, Quality

The State of Montana’s health plan was hemorrhaging money with a little over 60% of the costs coming from hospital care and pharmacy benefits. Enter Marilynn Bartlett, the Special Projects

Pharmacy Benefit Managers Grab Attention of HHS
Mar. 14, 2018 | Healthcare costs, Healthcare reform, PBM, Prescription Drug Pricing, Pricing transparency

March 14, 2018 HHS Secretary Alex Azar and FDA Commissioner Scott Gottlieb want pharmacy benefit managers (PBMs) and health plans to pass on more savings to consumers when they pick